par Moulin, Camilo;Metzger-Filho, Otto;Awada, Ahmad 
Référence Future oncology, 5, 6, page (785-802)
Publication Publié, 2009-08

Référence Future oncology, 5, 6, page (785-802)
Publication Publié, 2009-08
Article révisé par les pairs
Titre: |
|
Auteur: | Moulin, Camilo; Metzger-Filho, Otto; Awada, Ahmad |
Informations sur la publication: | Future oncology, 5, 6, page (785-802) |
Statut de publication: | Publié, 2009-08 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Bone-targeted therapy |
Hedgehog signaling pathway | |
Insulin growth factor pathway | |
MGMT methylation | |
Oncogenic addiction | |
Receptor tyrosine kinase | |
Signaling pathway | |
Tumor angiogenesis | |
Tyrosine kinase inhibitor | |
Uncommon neoplastic diseases | |
MeSH keywords: | Antineoplastic Agents -- pharmacology |
Antineoplastic Agents -- therapeutic use | |
Drug Delivery Systems -- trends | |
Drug Resistance, Neoplasm | |
Humans | |
Neoplasms -- drug therapy | |
Signal Transduction -- drug effects | |
Note générale: | Journal Article |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:1479-6694 |
info:doi/10.2217/fon.09.49 | |
info:scp/70349210825 | |
info:pmid/19663729 |